Turners Automotive【TRA】銘柄情報 | ADVFN

US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
オーストラリア
ASX
Turners Automotive Group Limited (TRA) 銘柄情報

Turners Automotive Group Limited (TRA)

4.30

0.00

(0.00%)

終了 11月23日 2:00PM

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

4.30

買値

3.50

売値

4.30

出来高

0.00

0.00 日の範囲 0.00

3.95 52 週間の範囲 4.48

時価総額

前日終値

4.30

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

469

発行済株式数

88,353,689

配当利回り

8.64%

PER

11.53

1 株当たり利益 (EPS)

0.37

歳入

416.73M

純利益

32.97M

セクター

Adjustment & Collection Svcs

業界

Misc Business Credit Instn

ウェブサイト

www.turnersautogroup.co.nz

本社

Auckland, Nzl

設立

1984

Turners Automotive Group Limited is listed in the Adjustment & Collection Svcs sector of the オーストラリア証券取引所 with ticker TRA. The last closing price for Turners Automotive was AUD4.30. Over the last year, Turners Automotive shares have traded in a share price range of AUD 3.95 to AUD 4.48.

Turners Automotive currently has 88,353,689 shares in issue. The market capitalisation of Turners Automotive is AUD379.92 million. Turners Automotive has a price to earnings ratio (PE ratio) of 11.53.

No news to show yet.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0.11	2.62529832936	4.19	4.3	4.17	537	4.27390261	DE
12	0	0	4.3	4.31	4.17	469	4.28960753	DE
26	0	0	4.3	4.48	4.17	390	4.3331558	DE
52	0.35	8.86075949367	3.95	4.48	3.95	750	4.21544348	DE
156	1.19	38.2636655949	3.11	4.48	3	1458	3.61383272	DE
260	2.05	91.1111111111	2.25	4.48	1.4	2360	2.72849667	DE

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
OECROrbital Corporation Limited	AUD 0.002 (100.00%)	6.95k
VPRVolt Group Ltd	AUD 0.0015 (50.00%)	3.24M
EWCEnergy World Corporation Ltd	AUD 0.023 (43.75%)	2.96M
PCLOPancontinental Energy NL	AUD 0.01 (42.86%)	3M
RMLResolution Minerals Ltd	AUD 0.002 (33.33%)	54.04k
ADNOCAndromeda Metals Limited	AUD 0.001 (-50.00%)	10.75M
RBRRBR Group Limited	AUD 0.001 (-50.00%)	5M
MTLMantle Minerals Limited	AUD 0.001 (-33.33%)	5.48M
EUROEuropean Lithium Limited	AUD 0.004 (-33.33%)	250k
ARDOArgent Minerals Ltd	AUD 0.002 (-33.33%)	1.41M
OVTOvanti Ltd	AUD 0.024 (-7.69%)	77.18M
CDECodeifai Ltd	AUD 0.001 (0.00%)	70.55M
SYASayona Mining Limited	AUD 0.035 (2.94%)	57.28M
PLSPilbara Minerals Limited	AUD 2.60 (-5.45%)	55.05M
TMKTMK Energy Ltd	AUD 0.0025 (25.00%)	46.43M

Truth_is_a_tool

Truth_is_a_tool 1分前

””Going to be a lot of angry people next week””

Who ? You and your multiple personalities ?! 🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣

NASDAQ2020

NASDAQ2020 1分前

Elite needs to continue on with DRUG C NDA
abuse deterrent opioid that contains no naltrexone
making it 90% cheaper than expensive SeQuestox

ramfan60

ramfan60 2分前

Nice.....I like him. He gets it.

#1 PATRIOTS_RSOX FAN

#1 PATRIOTS_RSOX FAN 2分前

Where is Dilution King Edward.

Come out come out wherever you are. POS

WebSlinger

WebSlinger 3分前

Here is a comment yesterday from the KBLB FB group:

"I sold my 500,000 shares this week. Lost a few 1000 in the process. Tired of waiting. 7yrs!"

Smartypants2

Smartypants2 3分前

XERIANT SRO (Europe) was a separate company started by Henry Biza that was supposed to bring foreign technologies (like Movychem's) to the attention of Xeriant (US). As best as I can determine, at some point Movychem decided to work directly with Xeriant (US). (Remember how Duffy had to fly to Easte

fza

Yeah, I think we all missed it. He must of mistakenly sent it to all his Buttbook friends. LOL

barrydingle

barrydingle 5分前

Nervous system overload

Information induced

urge2surge

urge2surge 6分前

You didn't see it because you weren't on the webinar. That was my take. Your now on my Iggy list.
Spin away all you want.

adesell

adesell 7分前

So now we know the "acquisition" was just a pump attempt. Failed even at that. LOL Revenues are down 90% year to year. Ticker symbol and cusip change is "75% completed" after over 2 years. Like I said...this is DONE. Trips by the end of the year. Mark it. Last ones with the million shares turn the l

WebSlinger

WebSlinger 7分前

Biowatch

Biowatch 8分前

FDA finds that asthma drug Singulair affects brain
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-finds-widely-used-asthma-drug-impacts-brain-2024-11-22/
-Singulair binds to brain receptors affecting psychiatric functions
-Merck spinoff Organon confident in S

weedtrader420

weedtrader420 8分前

Anyone calling for BITCOIN to dump is just jealous they don’t have no BITCOIN

silkcash

silkcash 8分前

Oh, I’m sorry I missed it. Can you repeat what Ben told you?

Gmenfan

Gmenfan 9分前

I'm e-mailing that one out. Thanks!!!!

NASDAQ2020

NASDAQ2020 10分前

That will reduce quotas for non-ADF IR Oxycodone.

ELTP

glenn1919

glenn1919 10分前

GRPO...................................https://stockcharts.com/h-sc/ui?s=GPRO&p=W&b=5&g=0&id=p86431144783

weedtrader420

weedtrader420 11分前

☕️🫖🫲😁👍 he doesn’t have a clue he doesn’t even have a cell phone. he has to go to the library to use computer.🤣😂🤣 amusements only $120k target thanksgiving

barrydingle

barrydingle 11分前

And the panicy insiders

This guy warns about "having numbers" and to watch out?
We have the numbers and a whole lot more.
Have you noticed that the mention of BLLB control person LILY RHODEHAMEL sets them off?

BurgerKing82

BurgerKing82 11分前

Steady volume here

glenn1919

glenn1919 11分前

COMM............................https://stockcharts.com/h-sc/ui?s=COMM&p=W&b=5&g=0&id=p86431144783

Canna_Business

Canna_Business 11分前

Pathway to Medical Cannabis: Saving Lives Through Policy and Innovation

1. DEA Action: Removing cannabis from Schedule 1 enables life-saving research, unlocking safer alternatives to opioids.

2. FDA Research: Clinical trials confirm cannabis is effective for chronic pai

Canna_Business

Canna_Business 11分前

Pathway to Medical Cannabis: Saving Lives Through Policy and Innovation

1. DEA Action: Removing cannabis from Schedule 1 enables life-saving research, unlocking safer alternatives to opioids.

2. FDA Research: Clinical trials confirm cannabis is effective for chronic pai

glenn1919

glenn1919 12分前

PLBY........https://stockcharts.com/h-sc/ui?s=PLBY&p=W&b=5&g=0&id=p86431144783

Turners Automotive

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約